188 related articles for article (PubMed ID: 28712768)
1. Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.
Lucar O; Su B; Potard V; Samri A; Autran B; Moog C; Debré P; Vieillard V
EBioMedicine; 2017 Aug; 22():122-132. PubMed ID: 28712768
[TBL] [Abstract][Full Text] [Related]
2. Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients.
Marcelino R; Gramacho F; Martin F; Brogueira P; Janeiro N; Afonso C; Badura R; Valadas E; Mansinho K; Caldeira L; Taveira N; Marcelino JM
Sci Rep; 2021 Apr; 11(1):8993. PubMed ID: 33903642
[TBL] [Abstract][Full Text] [Related]
3. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
[TBL] [Abstract][Full Text] [Related]
4. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
Curriu M; Fausther-Bovendo H; Pernas M; Massanella M; Carrillo J; Cabrera C; López-Galíndez C; Clotet B; Debré P; Vieillard V; Blanco J
PLoS One; 2012; 7(2):e30330. PubMed ID: 22312424
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses.
Ranasinghe S; Soghoian DZ; Lindqvist M; Ghebremichael M; Donaghey F; Carrington M; Seaman MS; Kaufmann DE; Walker BD; Porichis F
J Virol; 2015 Dec; 90(5):2208-20. PubMed ID: 26656715
[TBL] [Abstract][Full Text] [Related]
6. Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope.
Dorgham K; Pietrancosta N; Affoune A; Lucar O; Bouceba T; Chardonnet S; Pionneau C; Piesse C; Sterlin D; Guardado-Calvo P; Karoyan P; Debré P; Gorochov G; Vieillard V
J Immunol Res; 2019; 2019():9804584. PubMed ID: 31019982
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
[TBL] [Abstract][Full Text] [Related]
8. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
Vieillard V; Costagliola D; Simon A; Debré P;
AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
[TBL] [Abstract][Full Text] [Related]
9. Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation.
Bonduelle O; Chaudesaigues C; Tolazzi M; Suleiman E; de Bernard S; Alves K; Nourikyan J; Bohec M; Baudrin LG; Katinger D; Debré P; Scarlatti G; Vieillard V; Combadière B
Front Immunol; 2022; 13():848571. PubMed ID: 35464449
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
[TBL] [Abstract][Full Text] [Related]
11. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
12. Similar neutralizing activity in the HIV-1 infected long term non-progressors(LTNPs) and typical progressors(TPs).
Wang Z; Li TY; Li JY; Chen LL; Liu YJ; Li HP; Bao ZY; Wang XL; Zhuang DM; Liu SY; Li L
Virol Sin; 2012 Jun; 27(3):165-71. PubMed ID: 22684470
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
14. Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein.
Hicar MD; Chen X; Sulli C; Barnes T; Goodman J; Sojar H; Briney B; Willis J; Chukwuma VU; Kalams SA; Doranz BJ; Spearman P; Crowe JE
PLoS One; 2016; 11(7):e0158861. PubMed ID: 27411063
[TBL] [Abstract][Full Text] [Related]
15. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
Carotenuto P; Looij D; Keldermans L; de Wolf F; Goudsmit J
AIDS; 1998 Sep; 12(13):1591-600. PubMed ID: 9764777
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile in long-term non progressor HIV infected patients: in search of potential resistance factors.
Luque MC; Santos CC; Mairena EC; Wilkinson P; Boucher G; Segurado AC; Fonseca LA; Sabino E; Kalil JE; Cunha-Neto E
Mol Immunol; 2014 Nov; 62(1):63-70. PubMed ID: 24967879
[TBL] [Abstract][Full Text] [Related]
20. Specific anti-gp41 antibodies predict HIV-1 disease progression.
Vieillard V; Crouzet J; Boufassa F; Sennepin A; Ho Tsong Fang R; Debré P; Meyer L
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):403-5. PubMed ID: 22732471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
